Introduction {#sec1}
============

The cell cycle is a fundamental cellular process that governs the ability of cells to divide. Control of the cell cycle is crucial for the generation of tissues from dividing stem cells, such as the development of the nervous system. Exit from the cell cycle is associated with the control of differentiation because differentiated cells tend to be postmitotic. Re-entry of differentiated neurons into the cell cycle leads to apoptosis ([@bib22]), although there are some examples where the cells have been shown to differentiate even if cell-cycle exit is prevented ([@bib37]). Recently, not only cell-cycle exit, but also the length of the cell cycle, in particular the G1 phase length, has been associated with the decision of cells to differentiate. During mouse cortical development, elongation of the G1 phase by inhibiting the G1 cyclin-dependent kinases (Cdk4/6) promotes neurogenesis, whereas shortening of G1 by overexpressing G1 kinase Cdk4/CyD1 promotes proliferative divisions ([@bib32; @bib33]). A correlation between cell cycle/G1 length and the propensity for differentiation has also been documented in embryonic stem cells ([@bib44; @bib18]) and neural progenitors in the chicken spinal cord ([@bib61]). Apart from G1, the other two phases of interphase, G2 and S, have also been linked to neuronal differentiation. Expanding progenitors in the mouse cortex have been shown to have a longer S phase ([@bib3]) and elongation of the G2 phase has also been shown to promote progenitor proliferation ([@bib43]), although in the latter case, the effect has been linked back to the shortening of the G1 phase. This is not surprising because G1 is the key cell-cycle phase where both intrinsic and extrinsic signaling pathways impinge to instruct the cell whether to go for another round of division or differentiate ([@bib28]).

Why do some progenitors have a longer cell-cycle/G1 phase? An intriguing observation is that in the cortex, progenitors with a longer G1 phase are nonpolar (basal progenitors) whereas progenitors with shorter G1 are apicobasally polarized (apical progenitors; [@bib3]). It is also known that in many systems such as *Drosophila* neuroblasts, and mouse, *Xenopus*, and chicken neuroepithelium, polarized progenitors have a lower propensity to differentiate than their nonpolar daughter cells ([@bib48]). These results point to a link between polarity and the cell cycle, however, a direct mechanistic link between these two biological processes is not known. Any such mechanism is likely to involve key regulators of cell-cycle progression, such as the cyclin/cyclin-dependent kinase (Cy/Cdk) complexes and their inhibitors (cyclin-dependent kinase inhibitors/CdkIs). Inhibition of Cdk activity by stronger association with CdkIs has been shown to trigger neuronal differentiation ([@bib31]). Conversely, loss of CdkIs has been shown to inhibit differentiation ([@bib10; @bib38; @bib60]).

Here, we have used the neuroectoderm of the *Xenopus* embryo to investigate how the apicobasal polarization of neural progenitor cells affects cell-cycle kinetics and consequently, neuronal differentiation. *Xenopus* neuroectoderm exhibits a clean segregation of polarized and nonpolar progenitors into two distinct layers and provides a simple and accessible model for answering such fundamental questions. In *Xenopus*, deep (inner) nonpolar cells have a high propensity to differentiate, whereas superficial (outer) apicobasally polarized neuroepithelial cells are intrinsically resistant to primary neuronal differentiation ([@bib14]). Using this system, we have previously shown that the key regulator of polarity, the atypical (serine-threonine) protein kinase C (aPKC) has an instructive role in promoting proliferation and suppressing differentiation in polarized progenitors ([@bib49]). In this paper, we show that, first, the cell-cycle kinetics of polarized and nonpolar neuroectodermal cells differ significantly, with polarized cells having shorter total cell-cycle length and shorter S and G1 phases than nonpolar cells. Overexpression of p27Xic1, a member of the CIP/KIP CdkI family, elongates the G1 phase of the cell cycle and promotes terminal differentiation during *Xenopus* primary neurogenesis, a phenotype opposite to that of overexpression of an activated membrane-targeted form of aPKC, aPKC-CAAX. aPKC-CAAX overexpression rescues the increased neuronal differentiation phenotype of p27Xic1 overexpression, as would be expected if aPKC counteracted the activity of p27Xic1. Then, we show that aPKC directly phosphorylates p27Xic1 in the N terminus of the protein. Phosphomimetic p27Xic1 shows reduced binding to the G1-S related cyclin-dependent kinase 2 (Cdk2), resulting in reduced inhibition and higher kinase activity, which in turn causes a faster cell cycle. This study thus identifies a direct mechanistic link between apicobasal cell polarity and the cell cycle.

Results {#sec2}
=======

Polarized and Nonpolar Neural Progenitors in *Xenopus* Neuroectoderm Have Different Cell-Cycle Kinetics {#sec2.1}
-------------------------------------------------------------------------------------------------------

Dual-pulse S phase labeling (DPSL) analysis on outer layer apicobasally polarized progenitors and inner layer nonpolar neural progenitors (both Sox3+), showed that polarized progenitors have a significantly shorter cell cycle length and a shorter S phase length than nonpolar progenitors at open neural plate stage, NF13 (T~C~, polarized versus nonpolar, mean ± SEM, 282 ± 14 min versus 411 ± 21 min, and T~S,~ polarized versus nonpolar, 40 ± 4 min versus 141 ± 14 min, [Figure 1](#fig1){ref-type="fig"}A). We also analyzed these progenitors for percentage of labeled mitoses (PLM) to estimate G2+1/2M phase length and compared them for their mitotic indices ([Figure 1](#fig1){ref-type="fig"}B). Putting the numbers together from these experiments (see [Supplemental Experimental Procedures](#app2){ref-type="sec"} available online for details) showed that polarized progenitors have a shorter G1 phase (T~G1~, 94 min versus 160 min for nonpolar cells) but a longer G2 phase than the nonpolar progenitors (T~G2~, 132 min versus 89 min). The lengths of mitoses were marginally different between the two layers (T~M~, 16 min versus 21 min) ([Figure 1](#fig1){ref-type="fig"}C). Thus, establishing the cell-cycle kinetic parameters for polarized and nonpolar progenitors showed that they differ significantly and that polarized progenitors cycle faster.

aPKC Promotes Neural Progenitor Proliferation and Affects Cell Cycle Length {#sec2.2}
---------------------------------------------------------------------------

Confirming our previous findings ([@bib49]), overexpression of constitutively active, membrane-targeted aPKC (aPKC-CAAX) suppressed neuronal differentiation, as judged by the reduction in the expression of a terminal differentiation marker *N-tubulin*. Conversely, nuclear dominant-negative aPKC (NLS-aPKC-NT) promoted neuronal differentiation as *N-tubulin* was enhanced ([Figure S1](#app2){ref-type="sec"} available online). Extending these observations further, we found that on aPKC-CAAX overexpression, *ElrC*, a marker of committed neural progenitors ([@bib10]), was also suppressed, whereas cells expressing the neural progenitor marker *Sox3* showed expansion (*Sox3+* area was increased on the injected side as shown by in situ hybridization) ([Figure S1](#app2){ref-type="sec"}). This suggested that aPKC-CAAX suppressed neuronal differentiation by promoting neural progenitor expansion. In aPKC-CAAX-overexpressing embryos, the number of Sox3+ progenitors on the injected side was significantly higher (shown by immunostaining, [Figure 2](#fig2){ref-type="fig"}A) and cells on the injected side had significantly shorter T~C~ and T~S~, than on the noninjected side, calculated by the DPSL technique. Control embryos overexpressing GFP-CAAX exhibited no such differences ([Figure 2](#fig2){ref-type="fig"}A).

To further see the effects of aPKC on different phases of the cell cycle, we treated and imaged HeLa Fucci cells ([@bib52]) for 48--60 hr in the presence of a myristoylated, cell-permeable inhibitor specific against aPKC ([@bib51]). Cells inhibited for aPKC showed significant lengthening of the total cell-cycle time (T~C~, 25.32 ± 0.58 hr versus 19.38 ± 0.45 hr for controls). This was mainly attributed to the lengthening of the G1 phase (T~G1~, 17.04 ± 0.47 hr versus 11.79 ± 0.51 hr for controls), with small effects observed in the early S phase (T~S~, 5.68 ± 0.78 hr than 3.38 ± 0.40 hr for controls). M phase length (T~M~) was not affected by the treatment. The effect on the length of S, G2, and M together (T~SG2M~, 14.15 ± 0.67 hr versus 10.92 ± 0.43 hr for controls) indicated that the G2 phase was also largely unaffected by the inhibitor treatment ([Figure 2](#fig2){ref-type="fig"}B and [Movies S1](#mmc2){ref-type="supplementary-material"}A and S1B).

Pseudosubstrate inhibitors against kinases have the highest specificity. The pseudosubstrate myristoylated inhibitor used here is highly specific and has no effect on classical and novel PKCs ([@bib56]). Nevertheless, these data were further substantiated by the experiment with a chemical inhibitor against aPKC, bisindolylmaleimide Gö6983. This inhibitor has been used previously to show that aPKC is involved in TE formation ([@bib20]) and can maintain ES cells in an undifferentiated state in the absence of LIF, through the inhibition of PKCζ ([@bib19]). Gö6983 showed similar effects on cell-cycle kinetics as shown by Myr inhibitor against aPKC ([Figure 2](#fig2){ref-type="fig"}B and [Movies S1](#mmc2){ref-type="supplementary-material"}A and S1C).

The Fucci data along with DPSL data suggested that both gain and loss of aPKC signaling activity affects cell cycle length via G1 and S phases, with G2 and M phases remaining largely unaffected. These data suggested that the effects of aPKC on progenitors' proliferation might be mediated via its effects on cell-cycle kinetics. To test this further, we investigated the interaction of aPKC with cell-cycle regulators.

aPKC Directly Phosphorylates CIP/KIP Cell-Cycle Inhibitor p27Xic1 Both In Vitro and In Vivo {#sec2.3}
-------------------------------------------------------------------------------------------

G1 kinases (Cdk4/6) and G1/S kinase (Cdk2) are positively regulated by CyD and CyE/A, respectively, and negatively regulated by a CIP/KIP family cyclin-dependent kinase inhibitor (CdkI) p27Xic1 ([@bib41]). Because cyclins D, E, A, and p27Xic1 are regulated by posttranslational modifications, mainly phosphorylations ([@bib1]), we analyzed them for being phosphorylation targets of aPKC. In vitro kinase assays showed that only bacterially expressed p27Xic1 is a direct phosphorylation target of GST-aPKC (commercially supplied) ([Figure 3](#fig3){ref-type="fig"}A and data not shown). The specificity of this in vitro phosphorylation was confirmed by performing the kinase assay in the presence of a pseudosubstrate inhibitor specific against aPKC ([@bib51]). This reduced the kinase signal in a dose-dependent manner ([Figure 3](#fig3){ref-type="fig"}B). To see if aPKC can phosphorylate p27Xic1 in a complex embryonic milieu as well, we performed in vitro kinase assay using embryonic lysate, instead of kinase buffer, as the medium for interaction between exogenous GST-p27Xic1 (bacterially expressed) and His-aPKC (commercially supplied). The result demonstrated that phosphorylated GST-p27Xic1 significantly increases in the presence of aPKC, whereas it drops down to basal level in the presence of pseudosubstrate inhibitor against aPKC ([Figure 3](#fig3){ref-type="fig"}C).

To further substantiate these observations in vivo, we performed in vivo kinase assay measuring the incorporation of γ-P32-labeled orthophosphate by p27Xic1, overexpressed in HeLa cells along with aPKC-CAAX or in the presence of myristoylated pseudosubstrate aPKC inhibitor. The experiment showed that p27Xic1 incorporated more orthophosphate when expressed along with aPKC-CAAX; the incorporation was reduced when the same cells were cultured in the presence of the inhibitor ([Figure 3](#fig3){ref-type="fig"}D). p27Xic1 and aPKC-CAAX also showed direct physical interaction in coimmunoprecipitation (coIP) assays. First, Flag-p27Xic1 and HA-aPKC-CAAX constructs were co-overexpressed in HeLa cells and HA-aPKC-CAAX was detected after IP of Flag-p27Xic1 using anti-Flag beads ([Figure 3](#fig3){ref-type="fig"}E). More importantly, the endogenous p27Xic1 and aPKC from embryonic lysate also showed direct physical interaction in coIP experiments where either p27Xic1 or aPKC is immunoprecipitated with antibodies and aPKC or p27Xic1 is detected by western blot in the pull-down, respectively ([Figures 3](#fig3){ref-type="fig"}F and [S2](#app2){ref-type="sec"}).

The effect of aPKC inhibitors on HeLa Fucci cell-cycle length ([Figure 2](#fig2){ref-type="fig"}B) suggested that human p27Kip1 might also be negatively regulated by aPKC and may be a phosphorylation target of aPKC. However, our in vitro kinase assay using immunoprecipitated p27Kip1 from HeLa cells showed that human p27Kip1 is not a direct phosphorylation target of aPKC (data not shown). This suggests that aPKC negatively regulates p27Kip1 in an indirect manner.

Regulation of p27Xic1 Activity by aPKC Likely Takes Place in the Cell Nucleus {#sec2.4}
-----------------------------------------------------------------------------

To gain some insight into where the interaction of aPKC and p27Xic1 may be taking place, we performed immunostaining on neurula stage embryos overexpressing Flag-p27Xic1 and HA-aPKC-CAAX. These showed that p27Xic1 was largely in the nucleus of the cells, and a portion of aPKC-CAAX, which was mostly localized to the cell cortex, was also found in the nucleus ([Figure S3](#app2){ref-type="sec"}). These findings are consistent with previous reports showing nuclear enrichment of p27Xic1 ([@bib16; @bib17]) and some nuclear localization of aPKC-CAAX ([@bib49]) and lend support to the idea that aPKC interacts with p27Xic1 in the nucleus. In our previous publication ([@bib49]), we showed that aPKC-CAAX is more active and nuclear than aPKC and hypothesized that after getting activated in the membrane, a small proportion of aPKC-CAAX is translocated to the nucleus. This suggests that although aPKC-CAAX is predominantly membrane localized and weakly nuclear, it is highly active and sufficient to influence nuclear events like interacting with p27Xic1 and modulating its activity.

aPKC Phosphorylates p27Xic1 in Its Cdk-Interaction Domain, Resulting in Its Reduced Binding to Cdks {#sec2.5}
---------------------------------------------------------------------------------------------------

To identify domains of p27Xic1 phosphorylated by aPKC, we performed immunocomplex kinase assays on Flag-tagged deletion constructs of p27Xic1. As shown in [Figure 4](#fig4){ref-type="fig"}A, the N-terminal and middle parts of the protein showed positive kinase signal whereas the C-terminal fragment showed no sign of phosphorylation during in vitro kinase assays. Phosphosite identification using liquid chromatography/tandem mass spectrometry (LC/MS/MS) analysis on Flag-p27Xic1 phosphorylated by aPKC in vitro (i.e., in vitro kinase reaction on immunoprecipitated/IPed Flag-p27Xic1 from HeLa cells) identified multiple phosphorylation sites with significant Ascore values (≥13, Ascore is a measurement of the confidence of phosphorylation; [@bib6]) within the N-terminal, Cdk-binding domain ([Figure 4](#fig4){ref-type="fig"}A). To see if the sites identified correspond to the phosphosites in vivo, similar LC/MS/MS analysis was carried out on Flag-p27Xic1 IPed from HeLa cells co-overexpressing it with HA-aPKC-CAAX. This analysis identified a phosphosite (T68) with a significantly high Ascore (Ascore = 27; [Figure 4](#fig4){ref-type="fig"}A), located within the Cdk interaction domain of p27Xic1; another site (T99, located immediately after the Cdk interaction domain) was picked with a low Ascore value (Ascore = 13; [Figure 4](#fig4){ref-type="fig"}A). None of these sites was identified on Flag-p27Xic1 IPed from HeLa cells overexpressing it alone. *Xenopus* p27Xic1 is 44% identical to human p27Kip1 and 40% identical to human p21Cip1 in the conserved N terminus. It also possesses a PCNA-like binding site characteristic of p21Cip1 in the C terminus ([@bib57]). The aPKC phosphosite in p27Xic1 (T68A) is not conserved in mammalian p27Kip1 but is conserved in mammalian p21Cip1 (although it has not been identified as an aPKC phosphosite by others) and p27Xic1 from zebrafish ([Figure 4](#fig4){ref-type="fig"}B), suggesting some degree of functional conservation linking aPKC activity and cell-cycle regulation; the other phosphosite identified (T99) shows no conservation with other members of CIP/KIP CdkIs.

Identification of aPKC phosphorylation sites prompted us to check if these phosphorylation events are functionally important by generating phospho (S/T to A) or phosphomimetic (S/T to E) mutants. Initial protein abundance experiments showed that the level of Flag-p27Xic1 protein is decreased in embryos injected with HA-aPKC-CAAX and increased in embryos injected with the dominant-negative HA-aPKC-NT ([Figure S4](#app2){ref-type="sec"}A). Protein stability experiments using cycloheximide showed that the half-life of overexpressed Flag-p27Xic1 was reduced when it was co-overexpressed in HeLa cells along with HA-aPKC-CAAX ([Figure S4](#app2){ref-type="sec"}B). However, nonphosphorylatable mutants (like T68A) were also destabilized in comparison to the wild-type protein, whereas phosphomimetic mutants (like T68E) of p27Xic1 appeared more stable (see [Figures S4](#app2){ref-type="sec"}C and S4D for examples), suggesting that the effect of aPKC phosphorylation on p27Xic1 stability is complex and cannot be reproduced by single amino acid changes.

Not only the stability of CdkIs, but also the inhibition of Cdk kinase activity by CdkIs has been shown to promote differentiation ([@bib27]). We tested whether the binding of p27Xic1 to Cdks is affected by aPKC phosphorylation, which could explain the shortening of G1 and S phases of cell cycle. p27Xic1 interacts with Cdk2 and Cdk4 and inhibits their kinase activities ([@bib21]). CoIP assays using HeLa cells co-overexpressing Flag-p27Xic1 along with either HA-Cdk2 or HA-Cdk4 showed that p27Xic1 binds to Cdk2 much stronger than to Cdk4 (data not shown). Similar coIP assays showed that phosphomimetic mutant T68E showed almost 50% reduction in its binding to Cdk2 in comparison to the wild-type p27Xic1 ([Figures 4](#fig4){ref-type="fig"}C, 4E, and [S5](#app2){ref-type="sec"}), whereas the phosphomutant T68A showed enhanced binding (increased by almost 140%) to Cdk2 ([Figures 4](#fig4){ref-type="fig"}D, 4E, and [S5](#app2){ref-type="sec"}). Other mutants showed binding similar to the wild-type p27Xic1 ([Figures 4](#fig4){ref-type="fig"}C, 4D, and [S5](#app2){ref-type="sec"}). These assays suggested that a single phosphorylation event at amino acid T68 of p27Xic1 by aPKC is enough to affect its interaction with Cdk2. Using Histone H1 as a substrate for active Cdk2/CyclinA, we found that in comparison to the wild-type p27Xic1, phosphomutant T68A abolished the kinase activity of Cdk2 almost completely, while the phosphomimetic mutant T68E had a negligible effect on Cdk2 activity in the same assay ([Figure 4](#fig4){ref-type="fig"}F). Taken together, these results mean that phosphorylation of p27Xic1 by aPKC essentially inhibits the activity of p27Xic1 by reducing its binding to Cdk2, which in turn results in failure to negatively regulate the Cdk2 kinase activity.

p27Xic1 Increases Neuronal Differentiation, and This Effect Is Rescued by aPKC {#sec2.6}
------------------------------------------------------------------------------

p27Xic1 overexpression by injecting mRNA has been shown to promote neurogenesis ([@bib60]), while its morpholino-mediated knockdown blocked neurogenesis and promoted progenitor proliferation ([@bib10]). Here, we have used DNA injections, because in *Xenopus* the G1 phase appears in post-mid-blastula transition cell cycles. We found that such p27Xic1 DNA injections promoted neurogenesis ([Figure 5](#fig5){ref-type="fig"}A) in a cell autonomous fashion ([Figure S6](#app2){ref-type="sec"}) and suppressed neural progenitor proliferation, consistent with results obtained previously with RNA overexpression.

A subset of p27Xic1-overexpressing embryos was used for fluorescence-activated cell sorting (FACS) cell-cycle profiling on isolated nuclei. Experimental embryos showed significantly higher percentage of nuclei in G1 phase than the control embryos (35.4% versus 27.4%), with a concomitant decrease of nuclei in S phase (40.7% versus 49.7% for control) and negligible effect on the proportion of nuclei in G2 phase (23.9% versus 22.9% for control, [Figure 5](#fig5){ref-type="fig"}B), indicating that G1 phase elongates and proliferation decreases upon p27Xic1 overexpression.

Whereas 89% of p27Xic1-injected embryos showed enhanced staining for *ElrC*, the percentage dropped to 33% with a milder phenotype when p27Xic1 was coinjected with aPKC-CAAX ([Figure 5](#fig5){ref-type="fig"}C). Thus, p27Xic1's overexpression phenotype of promoting neuronal differentiation was rescued by unilateral injection of aPKC-CAAX. The corresponding numbers for *N-tubulin* staining were 88% and 20% after overexpression of p27Xic1 alone or with aPKC-CAAX (data not shown). This supported the idea that aPKC promotes progenitor proliferation, at the expense of neuronal differentiation upstream of p27Xic1, by inhibiting its activity. The idea was further supported by the observation that the phosphomutant of p27Xic1 (T68A) could promote neuronal differentiation similar to p27Xic1, but aPKC-CAAX could not effectively rescue this effect ([Figure 5](#fig5){ref-type="fig"}C).

Lengthening the Cell Cycle via CDK Inhibition by Chemical Means Promotes Differentiation {#sec2.7}
----------------------------------------------------------------------------------------

To understand if the effects of aPKC and p27Xic1 activities on neuronal differentiation were mediated via their effects on the cell-cycle length, we manipulated the cell cycle of embryos by nongenetic, chemical means using Olomoucine (Olo), an inhibitor that lengthens the G1 phase by inhibiting the activity of G1 kinases ([@bib9]). FACS analysis of nuclei from embryos treated with Olo showed that experimental embryos had more nuclei in G1 and G2 phases than control embryos, with a corresponding decrease in the proportion of nuclei in S phase, suggesting a decrease in proliferation and an elongation of growth phases ([Figure 6](#fig6){ref-type="fig"}A). Experimental embryos also showed a significantly higher number of MyT1-positive cells (a marker of differentiated neurons, 12.53 ± 2.44 per section) than the DMSO controls (8.75 ± 0.38) ([Figures 6](#fig6){ref-type="fig"}B and 6C), supporting the idea that elongating G1 phase promotes differentiation.

Discussion {#sec3}
==========

Cell polarization and cell division are two fundamental biological processes that have been independently linked to cellular differentiation. In this work, we showed that apicobasal polarity and cell-cycle control are directly linked in neural progenitor cells in a way that leads to distinct differentiation potential of polarized versus nonpolar progenitors. Our work has uncovered a remarkable similarity in the endogenous cell-cycle kinetics of apicobasally polarized and nonpolar progenitors between *Xenopus* neuroectoderm and the mouse embryonic cortex ([@bib3]). In both cases, the total length of the cell cycle and the length of G1 in apicobasally polar progenitors (apical progenitors in the mouse, superficial progenitors in *Xenopus)* are shorter than those found in nonpolar ones (basal progenitors in the mouse, deep progenitors in *Xenopus*). In addition, in both cases, the basal nonpolar progenitors have a higher propensity to differentiate than the apicobasally polarized ones ([@bib14; @bib15]). Thus, although the *Xenopus* neuroectoderm shows a much simpler structure, some of the basic principles relating to the cell-cycle control during neurogenesis are highly conserved.

We have used this system to specifically address the role of the apicobasal polarity in controlling the cell cycle via the apically localized key kinase aPKC. aPKC is a ubiquitous kinase that gets activated in cell cortex in a PI-3,4,5-trisphosphate (PIP3)-dependent manner (reviewed by [@bib29]). Polarized cells are thought to contain a highly active pool of aPKC because it is recruited to the apical cortex and/or the junctional complexes ([@bib30; @bib35]) where it should get activated. Therefore membrane targeting of aPKC by attaching it to a CAAX motif makes it constitutively active and mimics the effects of apicobasal polarization on aPKC activity ([@bib34; @bib49]).

aPKC was the first molecule shown to promote the proliferation of polarized neuroblasts in *Drosophila* and neural progenitors in *Xenopus* both by gain- and loss-of-function experiments ([@bib46; @bib12; @bib13; @bib49]). From a mechanistic point of view, the interaction of apicobasal polarity kinase aPKC with the cell-cycle machinery in polarized cells was thought to be indirect, via the Hippo pathway (reviewed in [@bib24]). For example, aPKC phosphorylates and negatively regulates KIBRA, an upstream positive regulator of the Hippo pathway ([@bib8; @bib62]). Overexpression of aPKC mislocalizes apical Hippo to the cytoplasm with its negative regulator RASSF, leading to the dampening of the Hippo pathway and resulting in enhanced cell proliferation ([@bib25]).

Our current results establish a direct link between aPKC and the cell cycle in context of cell polarity. In this study, we show that aPKC-CAAX directly phosphorylates the nuclear cell cycle/cyclin-dependent kinase inhibitor p27Xic1. Phosphorylation primarily takes place in T68, located in the N-terminal domain, although we cannot exclude contribution from other sites. aPKC-CAAX overexpression leads to a faster cell cycle in the neuroectoderm with shorter G1 and S phases, decreased neuronal differentiation, and enhanced neural proliferation (this work and [@bib49]).

aPKC has also been shown to have a role in cell proliferation of nonpolarized cells. For example, aPKC has been shown to directly phosphorylate and degrade p21Cip1 in human colorectal (HCT116) cells ([@bib53]), to upregulate CyD1 transcription, and to reduce p27Kip1's nuclear translocation in a Ras-dependent manner in MCF7 cells ([@bib11]). We assume that these nonpolar cells have a basal activity of aPKC, which is further enhanced by recruitment to the apical membrane in polarized cells.

How does phosphorylation of p27Xic1 by polarity kinase aPKC lead to a faster cell cycle with shorter G1 and S phases? p27Xic1 physically interacts with Cdks and cyclins through its Cdk/Cy interaction domains and reduces the activities of G1 kinase (Cdk4/CyD), G1-S transition kinase (Cdk2/CyE) and S progression kinase (Cdk2/CyA) with different half-maximal inhibitory concentration values ([@bib57; @bib21]). Our data show that phosphomimetic p27Xic1 has a reduced ability to bind and inhibit Cdk2. Enhanced Cdk2 activity through CyE overexpression causes the cells to cycle faster through G1 and enter S phase prematurely ([@bib42]), whereas inhibition of CyE/Cdk2 complex delays entry into S phase ([@bib59]). Thus, inhibition of Cdk2 kinase activity by CdkIs, like p27Xic1, is key in inhibiting the cycling of progenitors and promoting their differentiation. We suggest that in polarized progenitors, unrestricted kinase activities of G1/S-specific Cdk/Cy complexes due to lower p27Xic1 activity would shorten their G1 phase and concomitantly promote S phase entry, thereby promoting their cycling and interfering with the ability to differentiate.

The prolongation of total cell-cycle length, and G1 in particular, as cells approach differentiation seems to be a widespread phenomenon ([@bib58; @bib18; @bib44]). Mechanistically, it is thought that elongation of the G1 phase promotes neuronal differentiation by providing sufficient time for the accumulation and posttranscriptional modification of differentiation-promoting factors, such as Neurogenin and NeuroD (reviewed in [@bib32; @bib26]). In support of this idea, it was recently shown that the activity of Neurogenin is controlled by time-dependent, rheostat-like sequential (de)phosphorylation events in a cell-cycle-dependent manner ([@bib2]).

In conclusion, our findings provide mechanistic evidence for a direct link between apicobasal polarity and the cell cycle through aPKC and p27Xic1, which is used during development to endow polarized neural progenitors with lower propensity for differentiation than their nonpolar counterparts. p27Xic1 has a complex mode of regulation, which includes phosphorylation, ubiquitination, and degradation in the nucleus, and changes in the activity through the cell cycle ([@bib16; @bib17; @bib36]). Regulation of aPKC is likely to be equally complex, including shuttling between the membrane and the nucleus ([@bib49]). One challenge for the future is to understand the dynamic interaction between aPKC and p27Xic1 during the cell cycle.

Experimental Procedures {#sec4}
=======================

Cell-Cycle Length Analysis {#sec4.1}
--------------------------

### Dual-Pulse S Phase Labeling {#sec4.1.1}

This method enables the estimation of the total cell-cycle length (T~C~) and S phase length (T~S~) by injecting two different thymidine analogs ([@bib39]). Embryos collected at open neural plate stage (NF13) were injected with ethynyl deoxyuridine (EdU, 2 × 10 nl, 10 mM in DMSO \[Life Technologies\]) in the neural plate midline at two different positions. After 2 hr incubation, bromodeoxyuridine (BrdU, 2 × 10 nL, 10 mM in DMSO \[Roche\]) was injected in the same place ([Figure 1](#fig1){ref-type="fig"}A). Embryos were fixed in MEMFA 30 min later and processed for EdU, BrdU, and Sox3 (as a marker of both polar and nonpolar neural progenitors) staining as described elsewhere ([@bib4]).

### Percentage of Labeled Mitoses Analysis {#sec4.1.2}

This method involves labeling the mitotic (phosphohistone H3/PH3 +) cells with a thymidine analog (EdU or BrdU) and gives an estimate of the lengths of total cell cycle, S and G2+1/2M phases, depending on the duration of the experiment ([@bib54; @bib43]). Embryos at NF13 were injected with EdU as described above and collected every 30 min until 240 min as the last point of our experiment ([Figure 1](#fig1){ref-type="fig"}B). Embryos were fixed, sectioned, and stained for EdU, PH3, and Sox3 as described elsewhere ([@bib4]).

### Cell-Cycle Profiling using Fluorescence-Activated Cell Sorting Analysis on Propidium Iodide-Stained Nuclei {#sec4.1.3}

Nuclei from NF15 embryos (20 per set) for FACS analysis were prepared as described elsewhere ([@bib23]), followed by cell-cycle profiling using a CyAn ADP flow cytometer from Beckman Coulter running Summit v4.3 software. The modfit analysis on the data was carried out using FloJo software.

### Live-Cell Imaging of HeLa Cells-Based Fucci Biosensor for Cell-Cycle Length Analysis {#sec4.1.4}

HeLa Fucci cells were maintained and propagated as described elsewhere ([@bib52]). Control and experimental cells with inhibitors were imaged on a heated stage at 37°C and 5% CO~2~ supply using NikonA1 confocal microscope for 2--3 days.

### Imaging and Data Analysis {#sec4.1.5}

For dual-pulse S phase labeling and percentage of labeled mitoses analyses, five to ten sections per embryo from the mid-anterior neural plate were imaged on a NikonA1 confocal microscope. Still and time-lapse (for Fucci) images were processed and analyzed using ImageJ software. All the statistical tests were performed using Prism graph-pad software. Normality of the data was checked using D'Agostino & Pearson omnibus normality test. Depending on the outcome of the normality test, appropriate tests for significance (mentioned in the figure legends) were chosen from the software and applied to the data.

Overexpression in Whole Embryos, X-Gal Staining, and Whole Mount In Situ Hybridization Followed by Sectioning {#sec4.2}
-------------------------------------------------------------------------------------------------------------

Animal experiments were approved by the University's Ethical Review Panel and were undertaken under UK Home Office project license PPL 70/7648. Culturing and overexpression in *Xenopus laevis* embryos were carried out as described elsewhere ([@bib49]). Staging was made according to the Nieuwkoop and Faber table of development (NF stages; [@bib40]). The following amounts of mRNA or DNA were injected: *aPKC-CAAX* 0.25--0.5 ng, *NLS-aPKC-NT* 0.25--0.5 ng, and *p27Xic1* 0.15 ng (0.075ng × 2); 0.5 ng *GFP* or *β-galactosidase (LacZ)* mRNA was coinjected as lineage tracer/control. Antisense probes *N-tubulin*, *ElrC*, *and Sox3* have been described ([@bib14; @bib10]). Fixation, X-gal staining, in situ hybridization, and sectioning were carried out as described elsewhere ([@bib7]).

Expression and Purification of GST-Tagged p27Xic1, In Vitro and In Vivo Kinase Assays {#sec4.3}
-------------------------------------------------------------------------------------

GST-p27Xic1 was expressed in BL21 *Escherichia coli* cells and purified as described by the plasmid supplier (GE Healthcare). For in vitro kinase assay, 20 μl of eluted GST-p27Xic1 was mixed with kinase buffer (20 mM Tris-HCl \[pH 7.5\] and 5 mM MgCl~2~), GST-aPKC (1 μl/0.1 μg, Calbiochem)/His-aPKC (1 μl/0.1 μg, Millipore), and γP32-radiolabelled ATP (1 μl, 0.37 MBq \[Perkin Elmer\]). The final 30 μl reaction was incubated at 30°C for 30 min, boiled with sample buffer, and loaded on 10%--12% polyacrylamide gel. Post-run, dried gel on Whatman paper was used to expose X-ray film to get an autoradiogram impression of the kinase reaction.

To perform in vitro kinase assays in an embryonic environment, the reaction was performed exactly as described above, except that instead of kinase buffer, NF13-14 embryonic lysate (as described below but without EDTA and EGTA) was used as the incubation medium with 10 μl (3.7 MBq) of γP32-radiolabelled ATP.

For in vivo kinase assays, HeLa cells were transfected with Flag-p27Xic1 alone or with HA-aPKC-CAAX. For inhibitor treatment, Flag-p27Xic1 transfected cells were incubated with the media containing the inhibitor for 24 hr. γP32-radiolabelled orthophosphate (Perkin Elmer) incorporation was performed as described elsewhere ([@bib5]), followed by immunoprecipitation of Flag-p27Xic1 and autoradiography as described above.

For the immunocomplex kinase assay, 10 μl of protein A/G Sepharose beads (Santa Cruz Biotechnology) was mixed with 100 μl of cleared lysate from HeLa cells (overexpressing the protein of interest) and 2--5 μg of mouse anti-Flag antibody (M2 clone \[Sigma\]). The tube was rotated overnight at 4°C. Washed beads were incubated with the kinase reaction mix as described above. Gel was run, dried, and exposed as described above.

For Histone H1 in vitro kinase assay, 0.5 μg of Histone H1 (Sigma), 100 ng of active Cdk2/CyclinA protein (Millipore), and 1 μl of γP32-radiolabelled ATP (0.37 MBq) were mixed with immunoprecipitated wild-type or mutant p27Xic1 in 1× kinase buffer and incubated at 30°C for 30 min. The reaction was stopped and autoradiography was performed as described above.

Cell Culture, Transfections, Coimmunoprecipitation, Whole Embryo Lysates, and Western Blot Analysis {#sec4.4}
---------------------------------------------------------------------------------------------------

HeLa cells were maintained and transfected as described elsewhere ([@bib49]). CoIP assays from HeLa cells overexpressing proteins of interest were performed as described elsewhere ([@bib47]). Proteins were immunoprecipitated using 5--10 μg of the following antibodies: mouse anti-Flag (M2 clone \[Sigma\]), mouse anti-HA (Sigma), and mouse anti-Myc (Santa Cruz Biotechnology). CoIP from embryos was performed using the Pierce Crosslink IP kit, following the manufacturer's protocol using rabbit anti-aPKC (C20 clone, Santa Cruz Biotechnology) and rabbit anti-p27Xic1 antibodies (custom made against the antigen as described by [@bib55]).

For making embryo lysates, embryos were dissociated in lysis buffer (50 mM Tris pH7.5 + 150 mM NaCl + 0.5% NP40 + 5 mM EDTA + 5 mM EGTA). Cleared lysates were used for western blot analysis. The following antibodies were used for detection: rat HA-HRP (Roche), mouse Flag-HRP (Sigma), mouse Myc-HRP (Santa Cruz Biotechnology), rabbit aPKC (C20 clone, Santa Cruz Biotechnology), rabbit anti-p27Xic1, and mouse anti-α-tubulin (DM1A clone \[Sigma\]).

Chemical Inhibitors {#sec4.5}
-------------------

Myristoylated pseudosubstrate inhibitor against aPKC (Invitrogen Life Technologies; [@bib51]) was used at a working concentration of 12.5 μM. Chemical inhibitor against aPKC (Gö6983 \[Calbiochem\] [@bib50]) was used at a working concentration of 5 μM. Olomoucine (Calbiochem; [@bib9]) was used at a working concentration of 120 μM.

Whole-Mount Antibody Staining, Cryosectioning, and Antibody Staining on Sections {#sec4.6}
--------------------------------------------------------------------------------

Antibody staining on sections and whole mounts was performed as described elsewhere ([@bib49]). The following primary and secondary antibodies were used: rat anti-HA (Roche), rabbit anti-Flag (Sigma), mouse anti-BrdU (MoBu clone \[Life Technologies\]), mouse anti-phosphohistoneH3 (Abcam) and rabbit anti-Sox3 (custom made; [@bib63]), rabbit anti-MyT1 (custom made; [@bib49]), Alexa488-coupled anti-mouse, and Alexa647-coupled anti-rabbit (Life Technologies).

Mass Spectroscopic Analysis {#sec4.7}
---------------------------

For phosphopeptide mapping, protein bands were Coomassie stained, excised and in situ digested with trypsin. LC/MS/MS analysis of phosphosites was performed at the Taplin Biological Mass Spectrometry Facility (Harvard Medical School) as described ([@bib45]). Please refer to the [Supplemental Experimental Procedures](#app2){ref-type="sec"} for information regarding sample preparation for MS analysis.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S6Movie S1. Time-Lapse Movie for HeLa Fucci Biosensor Treated with DMSO, aPKC-Specific Myristoylated Pseudosubstrate Inhibitor, and aPKC Inhibitor, Related to Figure 2BDocument S2. Article plus Supplemental Information
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This is an open access article under the CC BY license (<http://creativecommons.org/licenses/by/3.0/>).

![Polarized and Nonpolar Neural Progenitors Have Significantly Different Cell-Cycle Kinetics Parameters\
(A) Dual pulse S phase labeling (DPSL) technique applied on wild-type NF13 *Xenopus* embryos (a) and analyzed by sectioning (b) shows that outer polar progenitors have shorter cell cycle (T~C~) and S phase (T~S~) lengths than inner nonpolar progenitors (c, mean ± SEM).\
(B) Similar embryos were processed for percentage of labeled mitoses (PLM, to estimate T~G2+1/2M~) (a--c). Representative sections are shown in (b), in which white arrowheads show labeled mitoses for nonpolar progenitors, while yellow arrowheads show labeled mitoses for polarized progenitors. During the time course of the experiment, neural plate cells converge to the midline. Percentage of mitotic indices for polarized and nonpolar progenitors showed no differences (d, mean ± SEM).\
(C) Table summarizes different cell-cycle parameters for the two types of progenitors. See the [Experimental Procedures](#sec4){ref-type="sec"} and [Supplemental Experimental Procedures](#app2){ref-type="sec"} for details about the techniques and calculations of kinetic parameters. All scale bars represent 100 μM.](gr1){#fig1}

![Overexpressing Activated aPKC Causes Progenitor Proliferation and Shortens the Cell Cycle by Shortening G1 and S Phases\
(A) DPSL analysis (a) shows that embryos on the aPKC-CAAX injected side show higher number of Sox3+ progenitors (b and c) and have shorter cell cycle (T~C~) and S phase (T~S~) (c, mean ± SEM). Control embryos overexpressing GFP-CAAX showed no such differences. The scale bar in (Ab) represents 100 μM. See also [Figure S1](#app2){ref-type="sec"}.\
(B) Schematic of Fucci cell cycle biosensor, which can be visually used to measure the lengths of various phases of cell cycle, is shown (a). When live imaged in the presence of either a pseudosubstrate inhibitor (MyrPSI) or a chemical inhibitor (Gö6983/GO) against aPKC, HeLa Fucci cells showed a significant increase in cell-cycle length (T~C~) due to elongated G1 and early S phases (b, mean ± SEM). Time-lapse movies are shown in [Movies S1](#mmc2){ref-type="supplementary-material"}A--S1C.](gr2){#fig2}

![aPKC Directly Phosphorylates p27Xic1\
(A) In vitro kinase assays showing that aPKC phosphorylates bacterially expressed GST-p27Xic1. Myelin basic protein (MBP) was used as a positive marker for aPKC phosphorylation.\
(B) Specificity of the kinase reaction was confirmed by using a pseudosubstrate inhibitor of aPKC.\
(C) Kinase assay performed in an embryonic environment (using embryo lysate instead of kinase buffer) also confirmed p27Xic1 being a direct phosphorylation target of aPKC.\
(D) In vivo kinase assay shows that p27Xic1 incorporates higher amount of P32 when it is co-overexpressed along with aPKC-CAAX; the amount of incorporated P32 is lower when p27Xic1 in overexpressed in HeLa cells in the presence of pseudosubstrate inhibitor against aPKC.\
(E) CoIP of HA-aPKC-CAAX with Flag-p27Xic1 in HeLa cells shows that aPKC-CAAX and p27Xic1 interact physically.\
(F) Physical interaction between p27Xic1 and aPKC was confirmed for endogenous proteins from embryonic lysates by a coIP assay using antibodies against endogenous p27Xic1 and aPKC. See also [Figures S2](#app2){ref-type="sec"} and [S3](#app2){ref-type="sec"}.](gr3){#fig3}

![aPKC Phosphorylates p27Xic1 in Its Cdk-Interaction Domain, Leading to Its Weaker Binding and Inhibition of Cdk2\
(A) The schematic shows p27Xic1 protein with its key interaction domains. Boxes in the middle show N-terminal, C-terminal and middle fragments that were used for immunocomplex kinase assays that indicated that aPKC phosphorylates p27Xic1 in its N-terminal half of the protein. The amino acid sequence underneath represents the Cdk-interaction domain of p27Xic1. MS analysis of Flag-p27Xic1 post-kinase assays identified multiple phosphorylation sites within its Cdk interaction domain with significant confidence scores (Ascores ≥ 13) after aPKC phosphorylation of p27Xic1 in vitro (indicated by arrows), whereas phosphosite (T68) was picked with Ascore of 27 after in vivo kinase assay; another phosphosite (T99) was picked with Ascore of 13 (both indicated by asterisks).\
(B) Sequence alignment of the N-terminal half of *Xenopus* p27Xic1 with other CIP/KIP CdkIs shows that aPKC phosphosite T68 (with arrow) in p27Xic1 is conserved in mammalian p21Cip1 and fish p27Xic1; site T99 (with arrowhead) shows no conservation. Asterisks indicate fully conserved residues, whereas colons and periods indicate groups with strongly and weekly similar properties, respectively.\
(C--E) In coIP assays performed in HeLa cells, phosphomimetic mutant for the site (T68E) showed reduced binding against Cdk2, whereas phosphomutant for the same site (T68A) showed enhanced binding against Cdk2. See also [Figure S5](#app2){ref-type="sec"}. Quantitation for binding of wild-type and mutants p27Xic1 is shown in (E) (mean ± SEM).\
(F) Histone H1 kinase assay shows that phosphomutant T68A of p27Xic1 strongly inhibits Cdk2's kinase activity, whereas phosphomimetic p27Xic1 (T68E) had negligible effect on the kinase activity of Cdk2, in comparison to the wild-type and T99 mutants of p27Xic1. Left blot shows the autoradiogram while the right blot shows the corresponding IP/western blot control. See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}

![p27Xic1 Overexpression Promotes Neuronal Differentiation, and This Effect Is Rescued by Overexpression of aPKC-CAAX\
(A) The neuronal markers *N-tubulin* and *ElrC* were increased and progenitor marker *Sox3* was decreased on the p27Xic1 injected (right; arrows) side in the embryos, as seen on whole mounts and sections. See also [Figure S6](#app2){ref-type="sec"}.\
(B) FACS cell-cycle profiling on p27Xic1-overexpressing embryos shows a significantly higher percentage of nuclei in the G1 phase, compared to control embryos, suggesting an elongation of G1.\
(C) The increase in neuronal differentiation, observed by p27Xic1 overexpression, is rescued by coexpression of aPKC-CAAX, but it could not effectively rescue the ectopic neurogenesis caused by overexpression of phosphomutant p27Xic1 (T68A). Scale bars in (Aa) and (Ac) represent 500 μM and 50 μM respectively.](gr5){#fig5}

![Elongating G1 Phase by Nongenetic Means Promotes Neuronal Differentiation\
(A) Growing *Xenopus* embryos from NF10 to 20 in the presence of 120 μM olomoucine, an inhibitor of cyclin-dependent kinases and G1 progression, may elongate the G1 phase of the cell cycle, as indicated by the cell-cycle profiling of the nuclei isolated from NF20 embryos. Experimental embryos showed a higher number of nuclei in the G1 phase of the cell cycle than the control embryos.\
(B) Experimental embryos, when stained with neuronal differentiation marker MyT1, showed a significantly higher number of differentiated neurons in comparison to control (mean ± SEM).\
(C) Examples of sections from control and experimental embryos stained with MyT1 antibody (green). Nuclei are blue and scale bar represents 50 μM.](gr6){#fig6}
